Market revenue in 2023 | USD 305.1 million |
Market revenue in 2030 | USD 745.8 million |
Growth rate | 13.6% (CAGR from 2023 to 2030) |
Largest segment | Dna chips |
Fastest growing segment | Lab-on-chip |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Tissue Arrays, Cell Arrays, DNA Chips, Lab-on-chip, Protein Chips |
Key market players worldwide | Agilent Technologies Inc, PerkinElmer, Illumina Inc, Bio-Rad Laboratories Inc, Standard BioTools Inc, GE HealthCare Technologies Inc Common Stock, Thermo Fisher Scientific Inc, Qiagen NV, Randox |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biochip market will help companies and investors design strategic landscapes.
Dna chips was the largest segment with a revenue share of 37.92% in 2024. Horizon Databook has segmented the China biochip market based on tissue arrays, cell arrays, dna chips, lab-on-chip, protein chips covering the revenue growth of each sub-segment from 2018 to 2030.
The growing biotechnological and pharmaceutical sector has a direct positive impact on the growth of the biochip market. In addition, with the development of these industries, there is increased biotechnological development in China, which has led to an increase in the market share of biochips in the country.
Improving healthcare infrastructure and growing healthcare expenditure by pharmaceutical companies & the government are expected to drive the biochip market. For instance, the Chinese government launched an initiative of Precision Medicine that could amount to around USD 9 billion over the next 15 years.
In addition, in August 2019, China became the leader in precision medicine and made significant efforts to strengthen the capabilities of precision medicine in the country. Thus, the abovementioned factors are projected to drive the country’s market.
Horizon Databook provides a detailed overview of country-level data and insights on the China biochip market, including forecasts for subscribers. This country databook contains high-level insights into China biochip market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account